OGI — Organigram Holdings Share Price
- $183.43m
- $124.50m
- CA$161.64m
- 36
- 57
- 53
- 47
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.84 | ||
Price to Tang. Book | 0.87 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 1.54 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -23.56% | ||
Return on Equity | -24.42% | ||
Operating Margin | -44.86% |
Financial Summary
Year End 30th Sep | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CA$m | 80.41 | 86.8 | 79.16 | 145.81 | 161.64 | 160.67 | 183.22 | 67.04% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Organigram Holdings Inc. operates through its subsidiaries. The Company’s major wholly owned subsidiaries include Organigram Inc., 10870277 Canada Inc., The Edibles and Infusions Corporation (EIC), and Laurentian Organic Inc. (Laurentian). Organigram Inc. is a licensed producer (LP) of cannabis, cannabis-derived products and cannabis infused edibles in Canada. It is focused on producing cannabis for patients and adult recreational consumers, as well as developing international business partnerships. It has also developed and owns a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. It operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. 10870277 Canada Inc. is a special purpose holding company for the Company. EIC is a cannabis processor of confectionary goods.
Directors
- Peter Amirault NEC (61)
- Beena Goldenberg CEO (59)
- Derrick West CFO (54)
- James Fletcher CEX
- Megan Mccrae SVP
- Nathalie Batten VOP
- Julie Chamberlain VPR
- Borna Zlamalik VPR
- Paolo De Luca OTH (40)
- Timothy Emberg OTH
- Helen Martin OTH
- Dexter John IND (52)
- Geoffrey Machum IND (61)
- Ken Manget IND (59)
- Sherry Porter IND (66)
- Stephen Smith IND (64)
- Marni Wieshofer IND (59)
- Last Annual
- September 30th, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- April 6th, 2016
- Public Since
- November 24th, 2011
- No. of Employees
- 914
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 104,143,401
- Address
- 35 English Drive, MONCTON, E1E 3X3
- Web
- https://www.organigram.ca/
- Phone
- +1 5063841571
- Auditors
- KPMG LLP
Upcoming Events for OGI
OrganiGram Holdings Inc Annual Shareholders Meeting
Q1 2025 OrganiGram Holdings Inc Earnings Release
Similar to OGI
Acadia Healthcare
NASDAQ Global Select Market
Accolade
NASDAQ Global Select Market
Addus HomeCare
NASDAQ Global Select Market
Alignment Healthcare
NASDAQ Global Select Market
Amedisys
NASDAQ Global Select Market
FAQ
As of Today at 22:28 UTC, shares in Organigram Holdings are trading at $1.80. This share price information is delayed by 15 minutes.
Shares in Organigram Holdings last closed at $1.80 and the price had moved by +20.81% over the past 365 days. In terms of relative price strength the Organigram Holdings share price has underperformed the S&P500 Index by -8.48% over the past year.
The overall consensus recommendation for Organigram Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreOrganigram Holdings does not currently pay a dividend.
Organigram Holdings does not currently pay a dividend.
Organigram Holdings does not currently pay a dividend.
To buy shares in Organigram Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $1.80, shares in Organigram Holdings had a market capitalisation of $183.43m.
Here are the trading details for Organigram Holdings:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: OGI
Based on an overall assessment of its quality, value and momentum Organigram Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Organigram Holdings is $8.84. That is 391.32% above the last closing price of $1.80.
Analysts covering Organigram Holdings currently have a consensus Earnings Per Share (EPS) forecast of -CA$0.42 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Organigram Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -39.44%.
As of the last closing price of $1.80, shares in Organigram Holdings were trading +0.91% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Organigram Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.80.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Organigram Holdings' management team is headed by:
- Peter Amirault - NEC
- Beena Goldenberg - CEO
- Derrick West - CFO
- James Fletcher - CEX
- Megan Mccrae - SVP
- Nathalie Batten - VOP
- Julie Chamberlain - VPR
- Borna Zlamalik - VPR
- Paolo De Luca - OTH
- Timothy Emberg - OTH
- Helen Martin - OTH
- Dexter John - IND
- Geoffrey Machum - IND
- Ken Manget - IND
- Sherry Porter - IND
- Stephen Smith - IND
- Marni Wieshofer - IND